Screening of opportunistic Encephalitozoon intestinalis and Enterocytozoon bieneusi in immunocompromised patients in Slovakia
Language English Country Czech Republic Media print
Document type Journal Article
PubMed
31951694
DOI
10.21101/cejph.a5407
Knihovny.cz E-resources
- Keywords
- Encephalitozoon intestinalis, Enterocytozoon bieneusi, immunocompromised patients, microsporidia, monoclonal antibodies,
- MeSH
- Encephalitozoon isolation & purification MeSH
- Encephalitozoonosis diagnosis epidemiology MeSH
- Enterocytozoon isolation & purification MeSH
- Feces microbiology MeSH
- Immunocompromised Host * MeSH
- Humans MeSH
- Microsporidiosis diagnosis epidemiology MeSH
- Opportunistic Infections diagnosis microbiology MeSH
- Mass Screening * MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Slovakia epidemiology MeSH
OBJECTIVE: In recent years new infectious diseases, i.e. emerging or re-emerging diseases, have been coming to the forefront. Currently, microsporidia, considered to be a major cause of emerging and opportunistic infections particularly in immunocompromised individuals, are also included in this group. Therefore, the aim of our study was to map the prevalence of Encephalitozoon intestinalis and Enterocytozoon bieneusi infection in a group of patients and to compare it with the occurrence of specific antigens in immunocompetent people. METHODS: Detection of spores of both pathogens in faecal samples was performed by an immunofluorescence test using species-specific monoclonal antibodies. RESULTS: Positivity to E. intestinalis in 91 examined immunosuppressed patients reached 33% (30/91), while only 4.3% (3/70) of the control group samples were found to be positive (relative risk 7.7, p < 0.001). In case of E. bieneusi 14.3% (13/91) of immunocompromised patients were positive, as were 5.7% (4/70) of people from the control group (relative risk 2.5, p = 0.095). CONCLUSION: In case of development of any opportunistic infection, the infection is detected and removed in most cases at an early stage. The incidence of clinically manifested microsporidiosis in patients with immunodeficiency is rare as they are under constant medical supervision. However, we must not forget about opportunistic infections, and in case of any non-specific symptoms it is necessary to exclude or confirm the diagnosis for immediate treatment.
References provided by Crossref.org
